Allogene Therapeutics Enters Research Collaboration Directed at Enhancing Future Cancer Immunotherapies Read more
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis Read more
Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases Read more
BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices Read more
Poxel Initiates Phase 1b Multiple Ascending Dose (MAD) Trial for NASH Drug Candidate, PXL065 Read more
Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata Read more